LDOS Stock Recent News

GOLDEN, Colo. & RESTON, Va.--(BUSINESS WIRE)--Today, Lunar Outpost announced Leidos (NYSE:LDOS), a Fortune 500® innovation leader, has joined the Lunar Dawn team, led by Lunar Outpost. The two companies will collaborate to develop a human-rated Moon rover as part of NASA's Lunar Terrain Vehicle Services (LTVS) contract, alongside General Motors (GM), The Goodyear Tire & Rubber Company and MDA Space. Leidos brings to the team a focus on practices to protect the health and safety of the crew,.

STRL, AXS, LDOS & LRN's impressive interest coverage ratios highlight that these companies can withstand financial hardships.

Leidos (LDOS) concluded the recent trading session at $157.06, signifying a +0.62% move from its prior day's close.

Here is how Leidos (LDOS) and Textron (TXT) have performed compared to their sector so far this year.

Extensive Partnership Enhances Availability of Tactical IT Hardware Contracts to U.S. Military Service Branches and Government Agencies Extensive Partnership Enhances Availability of Tactical IT Hardware Contracts to U.S. Military Service Branches and Government Agencies

LDOS makes a strong case for investment in the Aerospace sector, given its solid earnings growth prospects, return on equity and rising backlog.

RESTON, Va. , Sept. 18, 2024 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE® 500 innovation company, announced that Tina Jonas has been appointed to the company's Board of Directors, effective September 25, 2024.

Leidos awarded contract to support Air and Missile Defense Architecture RESTON, Va. , Sept. 17, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS) and the Program Executive Office (PEO) for Missiles and Space (MS), the Short and Intermediate Effectors for Layered Defense Project Office, and the PEO MS Integrated Fires team, successfully conducted intercepts of Unmanned Aircraft System (UAS) and Cruise Missile (CM) test targets with the Indirect Fire Protection Capability Increment 2 (IFPC Inc 2) system.

Strong financial results, including an 8% YoY revenue growth and raised full-year guidance, justify, in my view, the ~40% surge in share price since February this year. The Health & Civil segment drove most of the growth, with an increase in operating margins from 13% to 24.3% YoY. Challenges in the international segment, particularly a $39 million UK writedown and VBA contract uncertainties, pose risks to future revenue.

In the latest trading session, Leidos (LDOS) closed at $152.85, marking a -1.89% move from the previous day.